A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia.
Fatemi
S H
SH
Stary
J M
JM
Hatsukami
D K
DK
Murphy
S E
SE
D016642:Bupropion / Q000627:therapeutic use*; D018592:Cross-Over Studies; D039721:Diagnostic and Statistical Manual of Mental Disorders; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D012559:Schizophrenia / Q000175:diagnosis / Q000453:epidemiology*; D012720:Severity of Illness Index; D012907:Smoking / Q000453:epidemiology*; D016540:Smoking Cessation / Q000379:methods; D000074606:Smoking Prevention; D013997:Time Factors
D018765:Dopamine Uptake Inhibitors; D016642:Bupropion